Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Sung-Hoon, Ahn, Jae-Sook, Yang, Deok-Hwan, Chul Park, Hyung, Bae, Soo-Young, Kim, Yeo-Kyeoung, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published: February, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337734/
https://www.ncbi.nlm.nih.gov/pubmed/22539923
http://dx.doi.org/10.1159/000337022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337734/
https://www.ncbi.nlm.nih.gov/pubmed/22539923
http://dx.doi.org/10.1159/000337022

Ejemplares similares